{"database": "lobbying", "table": "lobbying_activities", "rows": [[3199694, "b4d496a9-389a-4854-a9a7-75b1f8850d12", "Q2", "MARSHALL & POPP, LLC", 401105121, "ABBVIE INC.", 2024, "second_quarter", "PHA", "Issues related to the 340B drug discount program. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169).", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2024-07-18T14:42:08-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3199694"], "units": {}, "query_ms": 38.875207072123885, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}